Millipore Sigma Vibrant Logo
Atención: Nos hemos mudado. Los productos Merck Millipore ya no pueden adquirirse en MerckMillipore.comMás información

HTS216M ChemiSCREEN™ Membrane Preparation Recombinant Human α1D Adrenergic Receptor with N-terminal truncation

HTS216M
200 units  
Purchase on Sigma-Aldrich

Descripción

Replacement Information

Tabla espec. clave

SpeciesHost CellsProtein Target
Human Chem-1alpha1D
Description
Catalogue NumberHTS216M
Trade Name
  • ChemiScreen
  • Chemicon
DescriptionChemiSCREEN™ Membrane Preparation Recombinant Human α1D Adrenergic Receptor with N-terminal truncation
OverviewTruncated human ADRA1D cDNA encoding α1D lacking residues 2-79
Background InformationThe endogenous catecholamines epinephrine and norepinephrine have profound effects on smooth muscle activity, cardiac function, carbohydrate and fat metabolism, hormone secretion, neurotransmitter release, and central nervous system actions. These activities are mediated by GPCRs belonging to two subfamilies, the α- and β-adrenoceptors (Bylund et al., 1994). The three members of the α1 subclass of adrenoceptors, α1A, α1B and α1D, couple to Gq, and promote contraction of vascular and urinary tract smooth muscle, relaxation of intestinal smooth muscle, increased contractile force in the heart, and glycogenolysis and gluconeogenesis in the liver. The different subtypes have overlapping distributions and variably contribute to these effects depending on species and tissue. The α1D adrenergic receptor mediates smooth muscle contraction in several tissues. In the vasculature, activation of α1D increases blood pressure (Tanoue et al., 2002; Hosoda et al., 2005). In the urinary tract, α1D promotes bladder contraction. Antagonists of α1 receptors are used to treat bladder outlet obstruction, and this effect is thought to be mediated by α1D (Chen et al., 2005). The α1D adrenergic receptors has a relatively long N-terminal extracellular domain, and truncation of this domain has been shown to increase expression of the receptor at the cell surface (Pupo et al., 2003). Millipore's α1D membrane preparations, which contain a version of α1D lacking residues 2-79, are crude membrane preparations made from our proprietary stable recombinant cell lines to ensure high-level of GPCR surface expression; thus, they are ideal HTS tools for screening of agonists and antagonists of α1D. The membrane preparations exhibit a Kd of 0.4 nM for [3H]-prazosin. With 0.5 nM [3H]-prazosin, 5 µg/well α1D (Δ2-79) Membrane Prep typically yields greater than 5-fold signal-to-background ratio.
References
Product Information
FormatMembranes
PresentationLiquid in packaging buffer: 50 mM Tris pH 7.4, 10% glycerol and 1% BSA no preservatives.
Packaging method: Membranes protein adjusted to the indicated concentration in packaging buffer, rapidly frozen, and stored at -80°C.
Quality LevelMQ100
Applications
ApplicationHuman alpha1D GPCR membrane preparation for Radioligand binding Assays & GTPγS binding.
Key Applications
  • Radioligand binding assay
  • GTPγS binding
Application NotesRadioligand binding assay and GTPγS binding.
Biological Information
Entrez Gene Number
Gene Symbol
  • ADRA1D
  • ADRA1A
GPCR ClassA
Host CellsChem-1
Protein Targetalpha1D
Target Sub-FamilyAdrenergic
UniProt Number
Incubation ConditionsRECOMMENDED ASSAY CONDITIONS: Membranes are mixed with radioactive ligand and unlabeled competitor (see Figures 1 and 2 for concentrations tested) in binding buffer in a nonbinding 96-well plate, and incubated for 1-2 h. Prior to filtration, an FC 96-well harvest plate (Millipore cat. # MAHF C1H) is coated with 0.33% polyethyleneimine for 30 min, then washed with 50mM HEPES, pH 7.4, 0.5% BSA. Binding reaction is transferred to the filter plate, and washed 3 times (1 mL per well per wash) with Wash Buffer. The plate is dried and counted.

Binding buffer: 50 mM Hepes, pH 7.4, 5 mM MgCl2, 1 mM CaCl2, 0.2% BSA, filtered and stored at 4°C

Radioligand: [3H]-prazosin. (PerkinElmer NET-823 )

Wash Buffer: 50 mM Hepes, pH 7.4, 500mM NaCl , 0.1% BSA, filtered and stored at 4°C.

One package contains enough membranes for at least 200 assays (units), where a unit is the amount of membrane that will yield greater than 5-fold signal:background with 3H labeled prazosin at 0.5 nM
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Table 1. Signal:background and specific binding values obtained in a competition binding assay with varying amounts of α1D (Δ2-79) receptor membrane prep.
Product Usage Statements
10 µg/well 5 µg/well
Signal:Background 15.4 11.2
Specific Binding (cpm) 778.8 670.5

SPECIFICATIONS: 1 unit = 5 µg membrane preparation
Bmax for [3H]-prazosin binding: 4.23 pmol/mg protein
Kd for [3H]-prazosin binding: ~0.4 nM Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsMaintain frozen at -70°C. Product is stable for at least 6 months from the date of receipt when stored as directed. Do not freeze and thaw.
Packaging Information
Material Size200 units
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Número de referencia GTIN
HTS216M 04053252738104

Documentation

ChemiSCREEN™ Membrane Preparation Recombinant Human α1D Adrenergic Receptor with N-terminal truncation Ficha datos de seguridad (MSDS)

Título

Ficha técnica de seguridad del material (MSDS) 

Referencias bibliográficas

Visión general referenciasPub Med ID
Function of the lower urinary tract in mice lacking alpha1d-adrenoceptor.
Chen, Qin, et al.
J. Urol., 174: 370-4 (2005)  2004

15947692 15947692
Two alpha1-adrenergic receptor subtypes regulating the vasopressor response have differential roles in blood pressure regulation.
Hosoda, Chihiro, et al.
Mol. Pharmacol., 67: 912-22 (2005)  2004

Mostrar resumen
15598970 15598970
N-terminal truncation of human alpha1D-adrenoceptors increases expression of binding sites but not protein.
Pupo, Andre S, et al.
Eur. J. Pharmacol., 462: 1-8 (2003)  2003

12591089 12591089
The alpha(1D)-adrenergic receptor directly regulates arterial blood pressure via vasoconstriction.
Tanoue, Akito, et al.
J. Clin. Invest., 109: 765-75 (2002)  2002

11901185 11901185
Selectivity of the imidazoline alpha-adrenoceptor agonists (oxymetazoline and cirazoline) for human cloned alpha 1-adrenoceptor subtypes.
Horie, K, et al.
Br. J. Pharmacol., 116: 1611-8 (1995)  1994

8564227 8564227

Ficha técnica

Cargo
CHEMISCREEN™ MEMBRANE PREPARATION RECOMBINANT HUMAN a1D ADRENERGIC RECEPTOR with N-terminal truncation

Productos y aplicaciones relacionados

Familias de productos

Productos relacionados por: Brand Facete

Categorías

Life Science Research > Drug Discovery and Development > GPCR Cell Lines & Assays > GPCR Membrane Preparations
Life Science Research > Proteins and Enzymes > GPCR Membrane Preparations